Suchergebnisse - "Van Hise, Nicholas"

PubPharm (8)

1

Oritavancin Versus Daptomycin for Osteomyelitis Treatment After Surgical Debridement

enthalten in: Infectious diseases and therapy | 2024

von Van Hise, N. | Petrak, R. | Shah, K. | +3

2

Patient Perception of Route of Rectal Administration of Live Biotherapeutic Product for Recurrent Clostridioides difficile Infection

enthalten in: Patient preference and adherence | 2023

von Feuerstadt, P. | Oneto, C. | Tillotson, G. | +1

3

Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS-CoV-2

enthalten in: Clinical and translational science | 2021

von Petrak, R. | Skorodin, N. | Van Hise, N. | +23

4

Early Tocilizumab Dosing Is Associated With Improved Survival in Critically Ill Patients Infected With Severe Acute Respiratory Syndrome Coronavirus-2

enthalten in: Critical care explorations | 2021

von Petrak, R. | Van Hise, N. | Skorodin, N. | +6

5

A Real-World Assessment of Clinical Outcomes and Safety of Eravacycline : A Novel Fluorocycline

enthalten in: Infectious diseases and therapy | 2020

von Van Hise, N. | Petrak, R. | Skorodin, N. | +9

6

Treatment of Acute Osteomyelitis with Once-Weekly Oritavancin : A Two-Year, Multicenter, Retrospective Study

enthalten in: Drugs - real world outcomes | 2020

von Van Hise, N. | Chundi, V. | Didwania, V. | +5

7

Thrombolytic Therapy in Wake-Up Stroke Patients

enthalten in: Clinical neuropharmacology | 2017

von Stern, G. | Van Hise, N. | Urben, L. | +3

8

Efficacy of Oral Vancomycin in Preventing Recurrent Clostridium difficile Infection in Patients Treated With Systemic Antimicrobial Agents

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2016

von Van Hise, N. | Bryant, A. | Hennessey, E. | +3

CommentIn: Clin Infect Dis. 2016 Sep 1;63(5):654-5. - PMID 27358349

1
[1]